Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Morrys C. Kaisermann"'
Autor:
Sandeep Bansal, Martin Anderson, Antonio Anzueto, Nicola Brown, Chris Compton, Thomas C. Corbridge, David Erb, Catherine Harvey, Morrys C. Kaisermann, Mitchell Kaye, David A. Lipson, Neil Martin, Chang-Qing Zhu, Alberto Papi
Publikováno v:
npj Primary Care Respiratory Medicine, Vol 31, Iss 1, Pp 1-9 (2021)
Abstract Chronic obstructive pulmonary disease (COPD) treatment guidelines do not currently include recommendations for escalation directly from monotherapy to triple therapy. This 12-week, double-blind, double-dummy study randomized 800 symptomatic
Externí odkaz:
https://doaj.org/article/dac6017c105b4a2b8e947907b8317115
Autor:
Nicola C. Day, Subramanya Kumar, Gerard Criner, Mark Dransfield, David M. G. Halpin, MeiLan K. Han, C. Elaine Jones, Morrys C. Kaisermann, Sally Kilbride, Peter Lange, David A. Lomas, Neil Martin, Fernando J. Martinez, Dave Singh, Robert Wise, David A. Lipson
Publikováno v:
Respiratory Research, Vol 21, Iss 1, Pp 1-12 (2020)
Abstract Background This analysis of the IMPACT study assessed the cardiovascular (CV) safety of single-inhaler triple therapy with fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) versus FF/VI and UMEC/VI dual therapy. Methods IMPACT was a 5
Externí odkaz:
https://doaj.org/article/bc54e68176db4ca5a7f7fcc01003961a
Autor:
Gary T. Ferguson, Nicola Brown, Chris Compton, Thomas C. Corbridge, Kelly Dorais, Charles Fogarty, Catherine Harvey, Morrys C. Kaisermann, David A. Lipson, Neil Martin, Frank Sciurba, Marjorie Stiegler, Chang-Qing Zhu, David Bernstein
Publikováno v:
Respiratory Research, Vol 21, Iss 1, Pp 1-15 (2020)
Abstract Background The comparative efficacy of inhaled corticosteroid/long-acting muscarinic antagonist/long-acting β2-agonist (ICS/LAMA/LABA) triple therapy administered via single or multiple inhalers in patients with chronic obstructive pulmonar
Externí odkaz:
https://doaj.org/article/41a8de2104034afa8ba6a8ae1c6a62f7
Autor:
Alberto Papi, Mitchell Kaye, Morrys C. Kaisermann, Chang-Qing Zhu, Antonio Anzueto, Catherine Harvey, Sandeep Bansal, David Erb, Neil Martin, David A. Lipson, Chris Compton, Nicola Brown, Thomas C Corbridge, Martin Anderson
Publikováno v:
npj Primary Care Respiratory Medicine, Vol 31, Iss 1, Pp 1-9 (2021)
NPJ Primary Care Respiratory Medicine
NPJ Primary Care Respiratory Medicine
Chronic obstructive pulmonary disease (COPD) treatment guidelines do not currently include recommendations for escalation directly from monotherapy to triple therapy. This 12-week, double-blind, double-dummy study randomized 800 symptomatic moderate-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e710e8dd093a6ad1e2e3471bca346ac6
https://doaj.org/article/dac6017c105b4a2b8e947907b8317115
https://doaj.org/article/dac6017c105b4a2b8e947907b8317115
Autor:
Fernando J. Martinez, Peter Lange, Maggie Tabberer, MeiLan K. Han, David M.G. Halpin, Morrys C. Kaisermann, Robert A. Wise, Dave Singh, Gerard J. Criner, David A. Lipson, David A. Lomas, Mark T. Dransfield, Sally Kilbride, C. Elaine Jones, Steven Pascoe
Publikováno v:
Adv Ther
Advances in Therapy
Tabberer, M, Jones, C E, Kilbride, S, Halpin, D M G, Lomas, D A, Pascoe, S, Singh, D, Wise, R A, Criner, G J, Lange, P, Dransfield, M T, Han, M K, Martinez, F J, Kaisermann, M C & Lipson, D A 2020, ' Single-Inhaler Triple Therapy and Health-Related Quality of Life in COPD : The IMPACT Study ', Advances in Therapy, vol. 37, no. 9, pp. 3775-3790 . https://doi.org/10.1007/s12325-020-01409-8
Advances in Therapy
Tabberer, M, Jones, C E, Kilbride, S, Halpin, D M G, Lomas, D A, Pascoe, S, Singh, D, Wise, R A, Criner, G J, Lange, P, Dransfield, M T, Han, M K, Martinez, F J, Kaisermann, M C & Lipson, D A 2020, ' Single-Inhaler Triple Therapy and Health-Related Quality of Life in COPD : The IMPACT Study ', Advances in Therapy, vol. 37, no. 9, pp. 3775-3790 . https://doi.org/10.1007/s12325-020-01409-8
Introduction The phase 3 InforMing the PAthway of COPD (chronic obstructive pulmonary disease) Treatment (IMPACT) trial, single-inhaler therapy with fluticasone furoate (FF) 100 μg, umeclidinium (UMEC) 62.5 μg, and vilanterol (VI) 25 μg demonstrat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9246c9bd4d9c6b4c3ec7265b14e9aae3
https://doi.org/10.1007/s12325-020-01409-8
https://doi.org/10.1007/s12325-020-01409-8
Autor:
Neil R.W. Martin, C. Elaine Jones, Peter Lange, Nicola C. Day, Fernando J. Martinez, David A. Lomas, David M.G. Halpin, Sally Kilbride, Dave Singh, Morrys C. Kaisermann, David A. Lipson, Gerard J. Criner, MeiLan K. Han, Mark T. Dransfield, Robert A. Wise, Subramanya Kumar
Publikováno v:
Respiratory Research, Vol 21, Iss 1, Pp 1-12 (2020)
Day, N C, Kumar, S, Criner, G, Dransfield, M, Halpin, D M G, Han, M K, Jones, C E, Kaisermann, M C, Kilbride, S, Lange, P, Lomas, D A, Martin, N, Martinez, F J, Singh, D, Wise, R & Lipson, D A 2020, ' Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol and umeclidinium/vilanterol in patients with COPD : results on cardiovascular safety from the IMPACT trial ', Respiratory research, vol. 21 . https://doi.org/10.1186/s12931-020-01398-w
Respiratory Research
Day, N C, Kumar, S, Criner, G, Dransfield, M, Halpin, D M G, Han, M K, Jones, C E, Kaisermann, M C, Kilbride, S, Lange, P, Lomas, D A, Martin, N, Martinez, F J, Singh, D, Wise, R & Lipson, D A 2020, ' Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol and umeclidinium/vilanterol in patients with COPD : results on cardiovascular safety from the IMPACT trial ', Respiratory research, vol. 21 . https://doi.org/10.1186/s12931-020-01398-w
Respiratory Research
Background This analysis of the IMPACT study assessed the cardiovascular (CV) safety of single-inhaler triple therapy with fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) versus FF/VI and UMEC/VI dual therapy. Methods IMPACT was a 52-week, r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b15e5fac01e9768a179a6710488b0f87
http://link.springer.com/article/10.1186/s12931-020-01398-w
http://link.springer.com/article/10.1186/s12931-020-01398-w
Autor:
Isabelle Pouliquen, Shaila Shabbir, Jane H Bentley, Eric S. Bradford, Morrys C. Kaisermann, Muna Albayaty
Publikováno v:
Clinical Pharmacology in Drug Development
This study compared the pharmacokinetic (PK) profile of a new liquid formulation of mepolizumab with the established lyophilized formulation. In this open‐label, parallel‐group, single‐dose study (NCT03014674; GSK ID: 204958), healthy participa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4ac249825946af207510d6266e5df5c
https://doi.org/10.1002/cpdd.726
https://doi.org/10.1002/cpdd.726
Autor:
Morrys C. Kaisermann, Chang-Qing Zhu, Nicola Brown, Alberto Papi, Neil R.W. Martin, David A. Lipson, Thomas C. Corbridge, Kelly Dorais, Chris Compton, Antonio Anzueto, Catherine Harvey, Dany Obeid, David Erb, Mitchell Kaye, Sandeep Bansal
Publikováno v:
Chest. 158:A1705-A1707
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7cf84bce2289e5bf54a36c1770b7d7a0
https://doi.org/10.1016/j.chest.2020.08.1516
https://doi.org/10.1016/j.chest.2020.08.1516
Autor:
Gary T. Ferguson, Nicola Brown, Thomas C. Corbridge, Morrys C. Kaisermann, Kelly Dorais, David I. Bernstein, C. Compton, Chang-Qing Zhu, Neil Martin, David A. Lipson, C.M. Fogarty, M.A. Stiegler, Frank C. Sciurba, Catherine Harvey
Publikováno v:
B103. TREATMENT OF OBSTRUCTIVE LUNG DISEASE.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::194853ec3e580249db1c19f0fa04e1f8
https://doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a4295
https://doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a4295
Autor:
D. Obeid, M. Kaye, Morrys C. Kaisermann, David A. Lipson, S. Bansal, A. Papi, Nicola Brown, Chang-Qing Zhu, D. Erb, Thomas C. Corbridge, Kelly Dorais, Chris Compton, Neil Martin, Catherine Harvey
Publikováno v:
B103. TREATMENT OF OBSTRUCTIVE LUNG DISEASE.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a74e18a0ddb24a7e892b1e57b0d2945f
https://doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a4294
https://doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a4294